Geode Capital Management, LLC Haemonetics Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,125,416 shares of HAE stock, worth $93.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,125,416

Previous 1,085,076 3.72%

Holding current value

$93.1 Million

Previous $92.8 Million 3.52%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $2.87 Million - $3.44 Million	40,340 Added 3.72%	1,125,416 $96.1 Million
Q4 2023 Feb 13, 2024	BUY	$80.59 - $92.61 $4.15 Million - $4.77 Million	51,474 Added 4.98%	1,085,076 $92.8 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $3.48 Million - $3.94 Million	42,184 Added 4.25%	1,033,602 $92.6 Million
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $3.86 Million - $4.27 Million	47,696 Added 5.05%	991,418 $84.4 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $2.44 Million - $3.04 Million	33,570 Added 3.69%	943,722 $78.1 Million

Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $1.82 Million - $2.12 Million	24,628 Added 2.78%	910,152 $71.6 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $1.31 Million - $1.63 Million	20,740 Added 2.4%	885,524 $65.6 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $826,602 - $1.11 Million	-16,777 Reduced 1.9%	864,784 $56.4 Million
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $1.45 Million - $2.1 Million	33,205 Added 3.91%	881,561 $55.7 Million
Q4 2021 Feb 11, 2022	BUY	$49.55 - $74.59 $862,021 - $1.3 Million	17,397 Added 2.09%	848,356 $45 Million
Q3 2021 Nov 12, 2021	SELL	$57.6 - $70.59 $1.53 Million - $1.88 Million	-26,632 Reduced 3.11%	830,959 $58.7 Million
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $12.4 Million - $28.5 Million	240,178 Added 38.9%	857,591 $57.1 Million
Q1 2021 May 12, 2021	BUY	$111.01 - $139.48 $4.42 Million - $5.56 Million	39,860 Added 6.9%	617,413 $68.5 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $2.97 Million - $4.01 Million	33,413 Added 6.14%	577,553 $68.6 Million
Q3 2020 Nov 13, 2020	SELL	$75.65 - $93.58 $4.86 Million - $6.01 Million	-64,238 Reduced 10.56%	544,140 $47.5 Million
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $13.1 Million - $18.3 Million	-154,000 Reduced 20.2%	608,378 $54.5 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $1.05 Million - $1.72 Million	14,108 Added 1.89%	762,378 $76 Million
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $2.23 Million - $2.53 Million	19,509 Added 2.68%	748,270 $86 Million
Q3 2019 Nov 12, 2019	BUY	$117.16 - $138.52 $3.08 Million - $3.64 Million	26,259 Added 3.74%	728,761 $91.9 Million
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $3.33 Million - $4.9 Million	40,680 Added 6.15%	702,502 $84.5 Million
Q1 2019 May 14, 2019	BUY	$83.25 - $102.12 $2.76 Million - $3.38 Million	33,127 Added 5.27%	661,822 $57.9 Million
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $2.48 Million - $3.19 Million	27,344 Added 4.55%	628,695 $62.9 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.13 Million - $1.44 Million	-12,606 Reduced 2.05%	601,351 $68.9 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $7.78 Million - $10.4 Million	108,718 Added 21.52%	613,957 $55.1 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $1.76 Million - $2.16 Million	29,036 Added 6.1%	505,239 $37 Million
Q4 2017 Feb 13, 2018	SELL	$44.96 - $58.99 $180,514 - $236,844	-4,015 Reduced 0.84%	476,203 $27.7 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $1.01 Million - $1.13 Million	25,128 Added 5.52%	480,218 $21.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	455,090	455,090 $18 Million

Others Institutions Holding HAE

# of Institutions

310

Shares Held

50.1M

Call Options Held

161K

Put Options Held

56.3K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.25B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Haemonetics Corp Transaction History